A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.
about
Integrating cannabis into clinical cancer care.Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.Emerging trends in understanding chemotherapy-induced peripheral neuropathy.The role of screening tools in diagnosing neuropathic pain.Chemotherapy induced peripheral neuropathic painMechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.Medical cannabis: considerations for the anesthesiologist and pain physician.Cannabinoids in Medical Practice.Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity.Cannabis and Cannabinoids for Chronic Pain.Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer.Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
P2860
Q36685151-3A0B03EF-76A4-447F-ABB8-9C28E062D425Q37721641-97AAC418-7EA6-4530-87F1-20B5CA3A588FQ38133440-47DC82CE-D03D-4E5A-A9B2-050EC15EA384Q38222254-B25BEA8F-C474-40B5-A125-172E98B231E3Q38237393-8CC22AAA-2505-4FCF-A57E-3E7EEC7724A8Q38264622-9F8A50AE-1522-419B-82A7-6C556E7919B1Q38287745-48FF4A19-C8D2-447E-B18C-6C91BB4913DEQ38386497-84608F62-369D-4241-A5E0-A0CF571A0053Q38600704-74637841-5E2D-49E9-A4F0-7D9FF4F377A5Q38724380-CEE1C986-B855-48DD-81FA-E42A851A6B21Q41560629-3985C879-E245-4A55-BD08-7BABC3B787F1Q42129148-9F0EF050-7535-4892-A0F1-C0064663B6F8Q43075872-E6788FB1-156E-473F-B333-615B6A7A7D1DQ47958585-F8243E99-60C5-4435-A93D-070A71682413Q50206095-7E2794CE-9349-4D27-81AF-0A10DEB70335Q55397242-F2EB4E87-9EA0-439B-B878-7189A8EBE49EQ57174777-BCC51AA7-212C-4429-811E-D3C4062E3915
P2860
A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@ast
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@en
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@nl
type
label
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@ast
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@en
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@nl
prefLabel
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@ast
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@en
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@nl
P2093
P921
P1476
A double-blind, placebo-contro ...... rapy-induced neuropathic pain.
@en
P2093
Andrea G Hohmann
Mary E Lynch
Paula Cesar-Rittenberg
P304
P356
10.1016/J.JPAINSYMMAN.2013.02.018
P577
2013-06-04T00:00:00Z